Stockscreener 앱 받기
1.27
1.60%
0.02
시간 외 거래:
1.28
0.01
+0.79%
전일 마감가:
$1.25
열려 있는:
$1.25
하루 거래량:
1.23M
Relative Volume:
1.33
시가총액:
$155.37M
수익:
$34.16M
순이익/손실:
$-50.62M
주가수익비율:
-2.50
EPS:
-0.508
순현금흐름:
$703.00K
1주 성능:
-7.97%
1개월 성능:
-31.35%
6개월 성능:
-67.52%
1년 성능:
-71.65%
1일 변동 폭
$1.22
$1.28
1주일 범위
$1.22
$1.414
52주 변동 폭
$1.22
$4.96
Omniab Inc Stock (OABI) Company Profile
명칭
Omniab Inc
전화
510-250-7800
주소
5980 HORTON STREET, EMERYVILLE
OABI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.27 | 168.82M | 34.16M | -50.62M | 703.00K | -0.508 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-04-21 | 개시 | The Benchmark Company | Buy |
| 2023-04-13 | 개시 | Craig Hallum | Buy |
| 2023-02-22 | 개시 | Cowen | Outperform |
| 2023-02-13 | 개시 | H.C. Wainwright | Buy |
| 2022-12-20 | 개시 | Truist | Buy |
| 2022-12-16 | 개시 | Credit Suisse | Outperform |
| 2022-11-29 | 개시 | SVB Leerink | Outperform |
| 2022-11-28 | 개시 | Stifel | Buy |
모두보기
Omniab Inc 주식(OABI)의 최신 뉴스
OABI stock touches 52-week low at $1.25 amid market challenges - Investing.com Australia
OABI stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Northern Trust Corp Acquires 45,169 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deutsche Bank AG Increases Stake in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada
OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister
Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st
Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance
51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World
Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World
Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus
Director Makes Bold Move with Major OmniAb Stock Purchase - TipRanks
Insider Buying: Steven Love Acquires 25,000 Shares of OmniAb Inc (OABI) - GuruFocus
Director’s Bold Move: A Major Investment in OmniAb Stock - TipRanks
Insider Buying: John Higgins Acquires 65,000 Shares of OmniAb In - GuruFocus
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - marketscreener.com
Hsbc Holdings PLC Makes New Investment in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb’s (OABI) “Buy” Rating Reaffirmed at Benchmark - Defense World
OmniAb: Too Much Risk, Not Enough Reward (NASDAQ:OABI) - Seeking Alpha
OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript - MSN
OmniAb : May 2025 Corporate Overview - marketscreener.com
Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88 - simplywall.st
Dimensional Fund Advisors LP Increases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
RBC Capital Remains a Buy on OmniAb (OABI) - The Globe and Mail
OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates - MSN
OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks
OmniAb Introduces the xPloration® Partner Access Program - BioSpace
OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls By Investing.com - Investing.com South Africa
Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
OmniAb Introduces the xPloration(R) Partner Access Program - marketscreener.com
OmniAb Reports Steady Growth in Q1 2025 - TipRanks
OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls - Investing.com Nigeria
OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Barclays PLC - Defense World
OmniAb Inc (OABI) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Wells Fargo & Company MN Purchases 12,278 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Earnings call transcript: OmniAb’s Q1 2025 shows revenue growth and cost control - Investing.com
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
OmniAb Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights - Business Wire
OmniAb to Participate in Two Investor Conferences in November - marketscreener.com
Ratio Revelations: OmniAb Inc (OABI)’s Financial Metrics in the Spotlight - DWinneX
Veraxa and OmniAb to develop bispecific ADC tumour programme - Yahoo Finance
OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program - marketscreener.com
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program - The Manila Times
VERAXA Biotech AG and OmniAb, Inc. Announce Co-Discovery Alliance for Novel Bispecific Antibody Drug Conjugate Program Targeting Solid Tumors - Nasdaq
Omniab Inc (OABI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.89%
3.74%
자본화:
|
볼륨(24시간):